A phase II open-label trial of dacomitinib monotherapy in patients with HER2-positive advanced gastric cancer after failure of at least one prior chemotherapy regimen.
Do-Youn Oh
No relevant relationships to disclose
Keun-Wook Lee
No relevant relationships to disclose
Jae Yong Cho
No relevant relationships to disclose
Won Ki Kang
No relevant relationships to disclose
Sun Young Rha
No relevant relationships to disclose
Yung-Jue Bang
Consultant or Advisory Role - Pfizer
Honoraria - Pfizer
Research Funding - Pfizer